Lynn Tyler of the Indianapolis office authored an article for the American Intellectual Property Association (AIPLA) Biotechnology Committee's monthly e-newsletter, the Biotech Buzz. Lynn's Amgen, Inc. v. AbbVie Biotechnology Ltd. case summary was published in the February issue of the newsletter.
RELATED PEOPLE
Partner
Food, Drug and Device Practice Chair
F
317-231-7433
×
Subscribe
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you're interested in learning more about.
View Subscription Center
/Passle/6488d4630e7e25c9ac9f834a/SearchServiceImages/2023-10-27-22-14-47-460-653c3657aa16c1a78944a4ac.jpg)
/Passle/6488d4630e7e25c9ac9f834a/SearchServiceImages/2024-06-15-03-35-36-968-666d0c08c56a9fccba9e64ea.jpg)
/Passle/6488d4630e7e25c9ac9f834a/SearchServiceImages/2024-06-17-15-30-39-269-6670569f086c06c316400926.jpg)
/Passle/6488d4630e7e25c9ac9f834a/SearchServiceImages/2024-04-10-12-04-21-213-66168045b21e7b3ad70f8900.jpg)